Micronclean, a sterile cleanroom consumables specialist, has launched Alpha Plus and Beta Plus, new sterile disinfectants.
Following intensive research by Micronclean’s in-house R&D team, Alpha Plus and Beta Plus have been designed to specifically meet the rotational disinfectant requirements of Annex 1.
Further, both products contain patent-protected technology and have been proven to perform in both laboratory tests and in real world situations.
Micronclean has developed two new sterile disinfectants Alpha Plus and Beta Plus
Micronclean has decades of expertise in cleanroom disinfectants with thousands of customers in cleanrooms around the world.
In constantly striving ‘to introduce new technological solutions that change the shape of the markets we serve’ Micronclean routinely surveys, purchases and tests its competitors’ products as they are found in the marketplace.
Routine testing of our competitor’s disinfectant solutions revealed the surprising result that none of them passed the three standard tests for cleanroom disinfectant efficacy (EN13697, EN1276 and EN1650) although they were all claiming pass results.
Alpha Plus and Beta Plus have been designed to specifically meet the rotational disinfectant requirements of Annex 1
Driven by these results and the possibility of poor disinfectant performance in real world use, Micronclean has developed a patented technology that is used within Alpha Plus and Beta Plus, which pass these standard tests.
The efficacy of Alpha Plus and Beta Plus has also been confirmed by intensive field studies.
Michelle Simpson, Product Director at Micronclean, said: "We take our purpose of changing the shape of the markets we serve very seriously and Alpha Plus and Beta Plus allow our existing and new customers to directly benefit from our in-house R&D effort. Extensive testing has proved Alpha Plus and Beta Plus to be very effective in both laboratory settings and field trials."
